Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Nucleus matrix |
Domain |
PF15741 Ligand-dependent nuclear receptor-interacting factor 1 |
Function |
Represses the ligand-induced transcriptional activity of retinoic acid receptor alpha (RARA). This repression may occur through direct recruitment of histone deacetylases. |
Biological Process | - |
Molecular Function |
GO:0008134 transcription factor binding GO:0035257 nuclear hormone receptor binding GO:0042974 retinoic acid receptor binding GO:0051427 hormone receptor binding |
Cellular Component |
GO:0000781 chromosome, telomeric region GO:0000784 nuclear chromosome, telomeric region GO:0016363 nuclear matrix GO:0034399 nuclear periphery GO:0044454 nuclear chromosome part GO:0098687 chromosomal region |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between LRIF1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of LRIF1 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of LRIF1 in various data sets.
|
Points in the above scatter plot represent the mutation difference of LRIF1 in various data sets.
|
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of LRIF1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of LRIF1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by LRIF1. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of LRIF1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of LRIF1 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between LRIF1 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | LRIF1 |
Name | ligand dependent nuclear receptor interacting factor 1 |
Aliases | FLJ11269; receptor interacting factor 1; C1orf103; chromosome 1 open reading frame 103; receptor-interacting ...... |
Chromosomal Location | 1p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting LRIF1 collected from DrugBank database. |
There is no record. |